Annual D&A
N/A
December 1, 2024
Summary
- FENC annual depreciation & amortization is not available.
Performance
FENC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
December 1, 2024
Summary
- FENC quarterly depreciation & amortization is not available.
Performance
FENC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
December 1, 2024
Summary
- FENC TTM depreciation & amortization is not available.
Performance
FENC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
FENC Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
FENC Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time |
Fennec Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $25.00 K(-3.8%) | $774.00 K(+3.3%) |
Jun 2024 | - | $26.00 K(-96.4%) | $749.00 K(+11.6%) |
Mar 2024 | - | $723.00 K(>+9900.0%) | $671.00 K(>+9900.0%) |
Sep 2023 | - | $0.00(-100.0%) | $0.00(0.0%) |
Jun 2023 | - | -$52.00 K(-200.0%) | $0.00(-100.0%) |
Mar 2023 | - | $52.00 K(+116.7%) | $52.00 K(-68.3%) |
Dec 2008 | $164.00 K(-14.6%) | $24.00 K(+71.4%) | $164.00 K(+1.9%) |
Sep 2008 | - | $14.00 K(-71.4%) | $161.00 K(-20.7%) |
Jun 2008 | - | $49.00 K(-36.4%) | $203.00 K(-4.2%) |
Mar 2008 | - | $77.00 K(+266.7%) | $212.00 K(+10.4%) |
Dec 2007 | $192.00 K(-92.1%) | $21.00 K(-62.5%) | $192.00 K(-92.0%) |
Sep 2007 | - | $56.00 K(-3.4%) | $2.41 M(-0.7%) |
Jun 2007 | - | $58.00 K(+1.8%) | $2.42 M(-0.1%) |
Mar 2007 | - | $57.00 K(-97.5%) | $2.42 M(-0.1%) |
Dec 2006 | $2.43 M(-20.5%) | $2.24 M(+3005.6%) | $2.43 M(+154.7%) |
Sep 2006 | - | $72.00 K(+20.0%) | $953.10 K(-42.2%) |
Jun 2006 | - | $60.00 K(0.0%) | $1.65 M(-29.7%) |
Mar 2006 | - | $60.00 K(-92.1%) | $2.35 M(-23.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2005 | $3.06 M(+21.3%) | $761.10 K(-1.0%) | $3.06 M(+33.2%) |
Sep 2005 | - | $768.80 K(+1.7%) | $2.29 M(+6.0%) |
Jun 2005 | - | $756.10 K(-1.7%) | $2.16 M(+8.6%) |
Mar 2005 | - | $769.00 K(+20.3%) | $1.99 M(-22.0%) |
Sep 2004 | - | $639.00 K(+9.2%) | $2.56 M(+1.5%) |
Jun 2004 | $2.52 M(+56.8%) | $585.30 K(-12.8%) | $2.52 M(-5.7%) |
Mar 2004 | - | $671.30 K(+1.8%) | $2.67 M(+2.9%) |
Dec 2003 | - | $659.50 K(+9.6%) | $2.60 M(+18.9%) |
Sep 2003 | - | $601.90 K(-18.5%) | $2.18 M(+36.0%) |
Jun 2003 | $1.61 M(+1195.0%) | $738.20 K(+23.7%) | $1.61 M(+76.3%) |
Mar 2003 | - | $596.70 K(+141.4%) | $910.60 K(+164.3%) |
Dec 2002 | - | $247.20 K(+943.0%) | $344.50 K(+178.0%) |
Sep 2002 | - | $23.70 K(-44.9%) | $123.90 K(-0.1%) |
Jun 2002 | $124.00 K(+124.6%) | $43.00 K(+40.5%) | $124.00 K(+53.1%) |
Mar 2002 | - | $30.60 K(+15.0%) | $81.00 K(+60.7%) |
Dec 2001 | - | $26.60 K(+11.8%) | $50.40 K(+111.8%) |
Sep 2001 | - | $23.80 K | $23.80 K |
Jun 2001 | $55.20 K(+6.2%) | - | - |
Jun 2000 | $52.00 K | - | - |
FAQ
- What is the all time high annual D&A for Fennec Pharmaceuticals?
- What is the all time high quarterly D&A for Fennec Pharmaceuticals?
- What is the all time high TTM D&A for Fennec Pharmaceuticals?
What is the all time high annual D&A for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual depreciation & amortization is $3.06 M
What is the all time high quarterly D&A for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly depreciation & amortization is $2.24 M
What is the all time high TTM D&A for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high TTM depreciation & amortization is $3.06 M